- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: July 2011
- Public Summary Document (PSD) July 2011 PBAC Meeting - PDF
Denosumab – July 2011
Denosumab, solution for subcutaneous injection, 120 mg in 1.7 mL, Xgeva® - July 2011
Last updated
23 November 2011